C-reactive protein in the era of molecular medicine;La proteína C reactiva en los tiempos de la medicina molecular

Medicina Clinica

Volumn 125, Issue 20, 2005, Pages 775-777

  Torrabadella De Reynoso, Pablo ^a   Pérez Moltó, Hipólito ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

EDITORIAL; MOLECULAR BIOLOGY; MOLECULAR MECHANICS; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; SEPSIS; SPAIN;

EID: 29944443300     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(05)72187-4     Document Type: Editorial

References (26)

1. Tillett WS, Francis T Jr. Serological reactions in pneumonia with non-protein somatic fraction of pneumococcus. J Exp Med. 1930;52:561-71.
2. Di Napoli M, Schwaninger M, Cappelli R, Ceccarelli E, Di Gianfilippo G, Cristina Donati C, et al. Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke - a statement for health care professionals from the CRP Pooling Project Members. Stroke. 2005;36:1316-29.
3. Szmitko PE, Wang CH, Weisel RD, De Almeida JR, Anderson TJ, Verma S. New markers of inflammation and endothelial cell activation: part I. Circulation. 2003;108:1917-23.
4. Yeh ET, Willerson JT. Coming of age of C-reactive protein: using inflammation markers in cardiology. Circulation. 2003;107:370-2.
5. Verma S, Szmitko PE, Yeh ETH. C-reactive protein. Structure affects function. Circulation. 2004;109:1914-7.
6. Seller-Pérez G, Herrera-Gutiérrez ME, Lebrón- Gallardo M, De Toro-Peinado I, Martín-Hita L, Porras-Ballesteros JA. Valor de la determinación de la proteína C reactiva como marcador pronóstico y de infección en pacientes críticos. Med Clin (Barv). 2005;125:761-5.
7. Arévalo-Lorido JC, Carretero-Gómez J, Calvo-Romero JM, Romero-Requena JM, Pérez-Alonso JL, Gutiérrez-Montaño C, et al. Proteína C reactiva en la fase gauda del ictus. Med Clin (Barc). 2005;125:766-9.
8. Marshall JC, Vincent JL, Fink MP, Cook DJ, Rubenfeld G, Foster D. Measures, markers, and mediators: toward a staging system for clinical sepsis. A report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25-26, 2000. Crit Care Med. 2003;31:1560-7.
9. Mosca L. C-reactive protein - to screen or not to screen? N Engl J Med. 2002;347:1615-7.
10. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111:1805-12.
11. Torrabadella de Reynoso P, Salgado Remigio A. Sepsis grave y shock séptico: encrucijada de la inflamación y la coagulación. Med Clin (Barc). 2001;116:782-8.
12. Povoa P, Coelho L, Almeida E, Fernandes A, Mealha R, Moreira P, et al. C-reactive protein as a marker of infection in critically ill patients. Clin Microbiol Infect. 2005;11:101-8.
13. Aikawa N, Fujishima S, Endo S, Sekine I, Kogawa K, Yamamoto Y, et al. Multicenter prospective study of procalcitonin as an indicator of sepsis. J Infect Chemother. 2005;11:152-9.
14. Gibot S, Kolopp-Sarda MN, Béne MC, Cravoisy A, Levy B, Faure GC, et al. Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis. Ann Intern Med. 2004;141:9-15.
15. Gibot S, Cravoisy A, Kolopp-Sarda MN, Bene MC, Faure G, Bollaert PE, et al. Time-course of sTREM, procalcitonin, and C-reactive protein plasma concentrations during sepsis. Crit Care Med. 2005;33:792-6.
16. Cobb JP, Laramie JM, Stormo GD, Morrissey JJ, Shannon WD, Qiu Y, et al. Sepsis gene expression profiling: murine splenic compared with hepatic responses determined by using complementary DNA microarrays. Crit Care Med. 2002;30:2711-21.
17. Di Napoli M, Schwaninger M, Cappelli R, Ceccarelli E, Di Gianfilippo G, Donati C, et al. Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members. Stroke. 2005;36:1316-29.
18. Bartosik-Psujek H, Belniak E, Stelmasiak Z. Markers of inflammation in cerebral ischemia. Neurol Sci. 2003;24:279-80.
19. Audebert HJ, Rott MM, Eck T, Haberl RL. Systemic inflammatory response depends on initial stroke severity but is attenuated by successful thrombolysis. Stroke. 2004;35:2128-33.
20. Christensen H, Boysen G. C-reactive protein and white blood cell count increases in the first 24 hours after acute stroke. Cerebrovasc Dis. 2004;18:214-9.
21. Pedersen ED, Waje-Andreassen U, Vedeler CA, Aamodt G, Mollnes TE. Systemic complement activation following human acute ischaemic stroke. Clin Exp Immunol. 2004;137:117-22.
22. Di Napoli M, Papa F. Association between blood pressure and C-reactive protein levels in acute ischemic stroke. Hypertension. 2003;42:1117-23.
23. Winbeck K, Poppert H, Etgen T, Conrad B, Sander D. Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke. Stroke. 2002;33:2459-64.
24. Intiso D, Zarrelli MM, Lagioia G, Di Rienzo F, Checchia de Ambrosio C, Simone P, et al. Tumor necrosis factor alpha serum levels and inflammatory response in acute ischemic stroke patients. Neurol Sci. 2004;24:390-6.
25. Waje-Andreassen U, Krakenes J, Ulvestad E, Thomassen L, Myhr KM, Aarseth J, et al. IL-6: an early marker for outcome in acute ischemic stroke. Acta Neurol Scand. 2005;111:360-5.
26. Khreiss T, Jozsef L, Potempa LA, Filep JG. Conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells. Circulation. 2004;109:2016-22.